Literature DB >> 33635912

Transmission of SARS-CoV-2 in domestic cats imposes a narrow bottleneck.

Katarina M Braun1, Gage K Moreno2, Peter J Halfmann1,3, Emma B Hodcroft4, David A Baker2, Emma C Boehm1, Andrea M Weiler1,5, Amelia K Haj2, Masato Hatta1,3, Shiho Chiba1,3, Tadashi Maemura1,3, Yoshihiro Kawaoka1,3, Katia Koelle6, David H O'Connor2,5, Thomas C Friedrich1,5.   

Abstract

The evolutionary mechanisms by which SARS-CoV-2 viruses adapt to mammalian hosts and, potentially, undergo antigenic evolution depend on the ways genetic variation is generated and selected within and between individual hosts. Using domestic cats as a model, we show that SARS-CoV-2 consensus sequences remain largely unchanged over time within hosts, while dynamic sub-consensus diversity reveals processes of genetic drift and weak purifying selection. We further identify a notable variant at amino acid position 655 in Spike (H655Y), which was previously shown to confer escape from human monoclonal antibodies. This variant arises rapidly and persists at intermediate frequencies in index cats. It also becomes fixed following transmission in two of three pairs. These dynamics suggest this site may be under positive selection in this system and illustrate how a variant can quickly arise and become fixed in parallel across multiple transmission pairs. Transmission of SARS-CoV-2 in cats involved a narrow bottleneck, with new infections founded by fewer than ten viruses. In RNA virus evolution, stochastic processes like narrow transmission bottlenecks and genetic drift typically act to constrain the overall pace of adaptive evolution. Our data suggest that here, positive selection in index cats followed by a narrow transmission bottleneck may have instead accelerated the fixation of S H655Y, a potentially beneficial SARS-CoV-2 variant. Overall, our study suggests species- and context-specific adaptations are likely to continue to emerge. This underscores the importance of continued genomic surveillance for new SARS-CoV-2 variants as well as heightened scrutiny for signatures of SARS-CoV-2 positive selection in humans and mammalian model systems.

Entities:  

Mesh:

Year:  2021        PMID: 33635912      PMCID: PMC7946358          DOI: 10.1371/journal.ppat.1009373

Source DB:  PubMed          Journal:  PLoS Pathog        ISSN: 1553-7366            Impact factor:   7.464


  54 in total

1.  Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population.

Authors:  Marco Vignuzzi; Jeffrey K Stone; Jamie J Arnold; Craig E Cameron; Raul Andino
Journal:  Nature       Date:  2005-12-04       Impact factor: 49.962

2.  Genetic diversity of hepatitis B virus as an important factor associated with differences in clinical outcomes.

Authors:  Yasuhito Tanaka; Masashi Mizokami
Journal:  J Infect Dis       Date:  2006-11-21       Impact factor: 5.226

3.  Influenza A virus transmission bottlenecks are defined by infection route and recipient host.

Authors:  Andrew Varble; Randy A Albrecht; Simone Backes; Marshall Crumiller; Nicole M Bouvier; David Sachs; Adolfo García-Sastre; Benjamin R tenOever
Journal:  Cell Host Microbe       Date:  2014-10-23       Impact factor: 21.023

Review 4.  Disease severity in respiratory syncytial virus infection: Role of host genetic variation.

Authors:  Alireza Tahamtan; Fatemeh Sana Askari; Louis Bont; Vahid Salimi
Journal:  Rev Med Virol       Date:  2019-01-04       Impact factor: 6.989

5.  Viral and host factors related to the clinical outcome of COVID-19.

Authors:  Xiaonan Zhang; Yun Tan; Yun Ling; Gang Lu; Feng Liu; Zhigang Yi; Xiaofang Jia; Min Wu; Bisheng Shi; Shuibao Xu; Jun Chen; Wei Wang; Bing Chen; Lu Jiang; Shuting Yu; Jing Lu; Jinzeng Wang; Mingzhu Xu; Zhenghong Yuan; Qin Zhang; Xinxin Zhang; Guoping Zhao; Shengyue Wang; Saijuan Chen; Hongzhou Lu
Journal:  Nature       Date:  2020-05-20       Impact factor: 69.504

6.  Mammalian adaptation of influenza A(H7N9) virus is limited by a narrow genetic bottleneck.

Authors:  Hassan Zaraket; Tatiana Baranovich; Bryan S Kaplan; Robert Carter; Min-Suk Song; James C Paulson; Jerold E Rehg; Justin Bahl; Jeri C Crumpton; Jon Seiler; Michael Edmonson; Gang Wu; Erik Karlsson; Thomas Fabrizio; Huachen Zhu; Yi Guan; Matloob Husain; Stacey Schultz-Cherry; Scott Krauss; Ryan McBride; Robert G Webster; Elena A Govorkova; Jinghui Zhang; Charles J Russell; Richard J Webby
Journal:  Nat Commun       Date:  2015-04-08       Impact factor: 14.919

7.  Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.

Authors:  Xiaobo Yang; Yuan Yu; Jiqian Xu; Huaqing Shu; Jia'an Xia; Hong Liu; Yongran Wu; Lu Zhang; Zhui Yu; Minghao Fang; Ting Yu; Yaxin Wang; Shangwen Pan; Xiaojing Zou; Shiying Yuan; You Shang
Journal:  Lancet Respir Med       Date:  2020-02-24       Impact factor: 30.700

8.  Transmission of SARS-CoV-2 in domestic cats imposes a narrow bottleneck.

Authors:  Katarina M Braun; Gage K Moreno; Peter J Halfmann; Emma B Hodcroft; David A Baker; Emma C Boehm; Andrea M Weiler; Amelia K Haj; Masato Hatta; Shiho Chiba; Tadashi Maemura; Yoshihiro Kawaoka; Katia Koelle; David H O'Connor; Thomas C Friedrich
Journal:  PLoS Pathog       Date:  2021-02-26       Impact factor: 7.464

9.  Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model.

Authors:  Barry Rockx; Thijs Kuiken; Sander Herfst; Theo Bestebroer; Mart M Lamers; Bas B Oude Munnink; Dennis de Meulder; Geert van Amerongen; Judith van den Brand; Nisreen M A Okba; Debby Schipper; Peter van Run; Lonneke Leijten; Reina Sikkema; Ernst Verschoor; Babs Verstrepen; Willy Bogers; Jan Langermans; Christian Drosten; Martje Fentener van Vlissingen; Ron Fouchier; Rik de Swart; Marion Koopmans; Bart L Haagmans
Journal:  Science       Date:  2020-04-17       Impact factor: 47.728

10.  Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy.

Authors:  Hongjing Gu; Qi Chen; Guan Yang; Lei He; Hang Fan; Yong-Qiang Deng; Shibo Jiang; Shihui Sun; Cheng-Feng Qin; Yusen Zhou; Yanxiao Wang; Yue Teng; Zhongpeng Zhao; Yujun Cui; Yuchang Li; Xiao-Feng Li; Jiangfan Li; Na-Na Zhang; Xiaolan Yang; Shaolong Chen; Yan Guo; Guangyu Zhao; Xiliang Wang; De-Yan Luo; Hui Wang; Xiao Yang; Yan Li; Gencheng Han; Yuxian He; Xiaojun Zhou; Shusheng Geng; Xiaoli Sheng
Journal:  Science       Date:  2020-07-30       Impact factor: 47.728

View more
  34 in total

Review 1.  Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants.

Authors:  Cong Sun; Chu Xie; Guo-Long Bu; Lan-Yi Zhong; Mu-Sheng Zeng
Journal:  Signal Transduct Target Ther       Date:  2022-06-28

2.  Mutations in SARS-CoV-2 variants of concern link to increased spike cleavage and virus transmission.

Authors:  Alba Escalera; Ana S Gonzalez-Reiche; Sadaf Aslam; Ignacio Mena; Manon Laporte; Rebecca L Pearl; Andrea Fossati; Raveen Rathnasinghe; Hala Alshammary; Adriana van de Guchte; Keith Farrugia; Yiren Qin; Mehdi Bouhaddou; Thomas Kehrer; Lorena Zuliani-Alvarez; David A Meekins; Velmurugan Balaraman; Chester McDowell; Jürgen A Richt; Goran Bajic; Emilia Mia Sordillo; Marion Dejosez; Thomas P Zwaka; Nevan J Krogan; Viviana Simon; Randy A Albrecht; Harm van Bakel; Adolfo García-Sastre; Teresa Aydillo
Journal:  Cell Host Microbe       Date:  2022-01-21       Impact factor: 31.316

3.  Comment on "Genomic epidemiology of superspreading events in Austria reveals mutational dynamics and transmission properties of SARS-CoV-2".

Authors:  Michael A Martin; Katia Koelle
Journal:  Sci Transl Med       Date:  2021-10-27       Impact factor: 19.319

4.  Severe Acute Respiratory Syndrome Coronavirus 2 Transmission in Intercollegiate Athletics Not Fully Mitigated With Daily Antigen Testing.

Authors:  Gage K Moreno; Katarina M Braun; Ian W Pray; Hannah E Segaloff; Ailam Lim; Keith Poulsen; Jonathan Meiman; James Borcher; Ryan P Westergaard; Michael K Moll; Thomas C Friedrich; David H O'Connor
Journal:  Clin Infect Dis       Date:  2021-07-15       Impact factor: 9.079

5.  Population Bottlenecks and Intra-host Evolution During Human-to-Human Transmission of SARS-CoV-2.

Authors:  Daxi Wang; Yanqun Wang; Wanying Sun; Lu Zhang; Jingkai Ji; Zhaoyong Zhang; Xinyi Cheng; Yimin Li; Fei Xiao; Airu Zhu; Bei Zhong; Shicong Ruan; Jiandong Li; Peidi Ren; Zhihua Ou; Minfeng Xiao; Min Li; Ziqing Deng; Huanzi Zhong; Fuqiang Li; Wen-Jing Wang; Yongwei Zhang; Weijun Chen; Shida Zhu; Xun Xu; Xin Jin; Jingxian Zhao; Nanshan Zhong; Wenwei Zhang; Jincun Zhao; Junhua Li; Yonghao Xu
Journal:  Front Med (Lausanne)       Date:  2021-02-15

6.  SARS-CoV-2 evolution in animals suggests mechanisms for rapid variant selection.

Authors:  Laura Bashor; Roderick B Gagne; Angela Bosco-Lauth; Richard Bowen; Mark Stenglein; Sue VandeWoude
Journal:  bioRxiv       Date:  2021-03-09

Review 7.  Concerns about SARS-CoV-2 evolution should not hold back efforts to expand vaccination.

Authors:  Sarah Cobey; Daniel B Larremore; Yonatan H Grad; Marc Lipsitch
Journal:  Nat Rev Immunol       Date:  2021-04-01       Impact factor: 108.555

8.  SARS-CoV-2 within-host diversity and transmission.

Authors:  Katrina A Lythgoe; Matthew Hall; Luca Ferretti; Mariateresa de Cesare; George MacIntyre-Cockett; Amy Trebes; Monique Andersson; Newton Otecko; Emma L Wise; Nathan Moore; Jessica Lynch; Stephen Kidd; Nicholas Cortes; Matilde Mori; Rebecca Williams; Gabrielle Vernet; Anita Justice; Angie Green; Samuel M Nicholls; M Azim Ansari; Lucie Abeler-Dörner; Catrin E Moore; Timothy E A Peto; David W Eyre; Robert Shaw; Peter Simmonds; David Buck; John A Todd; Thomas R Connor; Shirin Ashraf; Ana da Silva Filipe; James Shepherd; Emma C Thomson; David Bonsall; Christophe Fraser; Tanya Golubchik
Journal:  Science       Date:  2021-03-09       Impact factor: 47.728

9.  SARS-CoV-2 under an elimination strategy in Hong Kong.

Authors:  Haogao Gu; Ruopeng Xie; Dillon C Adam; Joseph L-H Tsui; Daniel K Chu; Lydia D J Chang; Sammi S Y Cheuk; Shreya Gurung; Pavithra Krishnan; Daisy Y M Ng; Gigi Y Z Liu; Carrie K C Wan; Kimberly M Edwards; Kathy S M Leung; Joseph T Wu; Dominic N C Tsang; Gabriel M Leung; Benjamin J Cowling; Malik Peiris; Tommy T Y Lam; Vijaykrishna Dhanasekaran; Leo L M Poon
Journal:  medRxiv       Date:  2021-06-23

Review 10.  The Spike of Concern-The Novel Variants of SARS-CoV-2.

Authors:  Anna Winger; Thomas Caspari
Journal:  Viruses       Date:  2021-05-27       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.